| Phaarmasia Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 523620 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE486I01016 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 8.34 |
Market Cap(₹Cr) : 37.61 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 5.93 | 8.29 | 9.99 | 5.08 | 8.64 | 6.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 5.93 | 8.29 | 9.99 | 5.08 | 8.64 | 6.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.22 | 0.15 | 0.19 | 0.13 | 0.20 | 0.14 |
| Total Income | 6.15 | 8.44 | 10.18 | 5.21 | 8.84 | 7.02 |
| Total Expenditure | 6.71 | 8.11 | 9.66 | 5.64 | 8.92 | 7.20 |
| PBIDT | -0.56 | 0.33 | 0.53 | -0.43 | -0.08 | -0.18 |
| Interest | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 |
| PBDT | -0.57 | 0.33 | 0.52 | -0.46 | -0.08 | -0.18 |
| Depreciation | 0.08 | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -0.03 | -0.04 | 0.02 | -0.01 | 0.00 |
| Reported Profit After Tax | -0.64 | 0.28 | 0.47 | -0.56 | -0.16 | -0.27 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.64 | 0.28 | 0.47 | -0.56 | -0.16 | -0.27 |
| EPS (Unit Curr.) | -0.94 | 0.40 | 0.69 | -0.83 | -0.24 | -0.39 |
| EPS (Adj) (Unit Curr.) | -0.94 | 0.40 | 0.69 | -0.83 | -0.24 | -0.39 |
| Calculated EPS (Unit Curr.) | -0.94 | 0.40 | 0.69 | -0.83 | -0.24 | -0.39 |
| Calculated EPS (Adj) (Unit Curr.) | -0.94 | 0.40 | 0.69 | -0.83 | -0.24 | -0.39 |
| Calculated EPS (Ann.) (Unit Curr.) | -3.76 | 1.62 | 2.77 | -3.31 | -0.95 | -1.55 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -3.76 | 1.62 | 2.77 | -3.31 | -0.95 | -1.55 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -9.44 | 3.98 | 5.31 | -8.46 | -0.93 | -2.62 |
| PBDTM(%) | -9.61 | 3.98 | 5.21 | -9.06 | -0.93 | -2.62 |
| PATM(%) | -10.79 | 3.38 | 4.70 | -11.02 | -1.85 | -3.92 |